Neuroprotective potential of incretinomimetics

نویسندگان

چکیده

In the prescriptions of an endocrinologist to patients with diabetes mellitus, glucagon-like peptide agonists, belonging group that affects incretin system body, have recently been increasingly appearing. addition pronounced hypoglycemic effect and high safety, these drugs also many pleiotropic properties due presence receptors in vascular endothelium, kidneys, heart nervous tissue. The purpose this work is describe most studied neuroprotective effects class drugs. As materials course work, studies domestic foreign colleagues published period from 2008 2022 were used. Our has shown GLP-1 associated activation corresponding receptor systems central system, which leads increased cellular survival ischemic conditions by reducing reactive oxygen species, stimulating beta-oxidation mitochondria, pro-inflammatory cytokines. addition, analysis literature established positive role neurodegenerative diseases – reduce amount unnormal proteins (alphasynuclein, microtubular T-peptide, etc.), activity non-enzymatic glycation hyperglycemia, as well insulin resistance. described above analyzed during preclinical trials GLP-1, demonstrated their validity human models some clinical trials. However, data obtained not yet sufficient form clear indications for neurology, so topic requires further study large

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Potential neuroprotective strategies against tauopathy.

Tauopathies are neurodegenerative diseases, including AD (Alzheimer's disease) and FTLD-T (tau-positive frontotemporal lobar degeneration), with shared pathology presenting as accumulation of detergent-insoluble hyperphosphorylated tau deposits in the central nervous system. The currently available treatments for AD address only some of the symptoms, and do not significantly alter the progressi...

متن کامل

Mitochondrial Preconditioning: A Potential Neuroprotective Strategy

Mitochondria have long been known as the powerhouse of the cell. However, these organelles are also pivotal players in neuronal cell death. Mitochondrial dysfunction is a prominent feature of chronic brain disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD), and cerebral ischemic stroke. Data derived from morphologic, biochemical, and molecular genetic studies indicate th...

متن کامل

Neuroprotective effects of some newer and potential antiepileptic drugs

Experimental models of epilepsy or status epilepticus (SE) provide evidence that seizures result in diffuse brain damage. Other neurological conditions are also associated with neurodegeneration, for example, stroke, head injury and chronic neurodegenerative diseases. In this review, the neuroprotective effects of a number of newer or potential antiepileptic drugs (AEDs) are considered in gener...

متن کامل

Neuroprotective effect of lidocaine: is there clinical potential?

Local anesthetic lidocaine has been shown to be protective in animal models of focal and global ischemia as well as in in vitro hypoxic models. Lidocaine has been tested in patients for its potential protective effect on postoperative cognitive dysfunction. This mini-review summarizes the laboratory and clinical evidences and discusses its clinical applications as neuroprotective agent.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: ??????????? ?????

سال: 2023

ISSN: ['0235-1188', '2618-8961']

DOI: https://doi.org/10.21518/ms2023-159